Thus, targeting GPR10 and NPFFR2 receptors may be beneficial not only for obesity treatment but also for attenuating anxiety since the deficiency of both receptors resulted in anxiety-like behavior in dKO females. The gene discussed is PRLHR; the disease is Anxiety.